Ferring Launches Minirin Melts to Curb Kids’ Bedwetting

0
112

Ferring Pharmaceuticals has launched a new drug,  Minirin Melt (Desmopressin oral Lyophilisate) for the treatment of enuresis (bedwetting) in children.

The ceremony,  which was held recently at Protea Hotel, Alausa, Ikeja, Lagos and chaired by Professor Augustine Isikhuemen, president of Paediatric Association of Nigeria, had several physicians from all over the country in attendance.

At the launch of the new medication, two eminent physicians, Prof. Johan Vande Walle from Ghent University, Belgium, and Dr Chris Esezobor, an associate professor of paediatrics and paediatric nephrology, College of Medicine, University of Lagos, presented educative papers on “Treatment optimisation in children with monosymptomatic nocturnal enuresis: The role of Minirin Melt” and “Management of enuresis in Nigeria) Opportunities and challenges”.

L-R:Dr Chris Esezobor, associate professor of paediatrics and paediatric nephrology; Rowa’a Hijazi, strategic brand leader for Minirin; Prof Jehan Vande Walle, paediatric nephrologist from Ghent University, Belgium; Prof Augustine Isikhuemen, president of Paediatric Association of Nigeria; Pharm. Yemi Aladeniyi, country manager, Ferring Pharmaceuticals and Godfrey Ayoka, promotional manager, SSA, Ferring, during the event.

Speaking with Pharmanews at the event, Pharm. Yemi Aladeniyi, country manager for Ferring Pharmaceuticals, reaffirmed  the company’s purpose in helping people live better lives and also building healthier families, noting that this is the reason the company is looking for ways to take care of children, as it is meeting the needs of parents.

He stated that bedwetting is a major problem that is hardly talked about and usually mishandled, adding that research had shown that the ways the condition was being handled was having serious negative impacts on children.

He stated further that Ferring was introducing Minirin Melt 60/120 into the Nigerian market because the company believed it would be of great benefit to healthcare professionals treating enuresis, and families who have children with the condition.

Pharm. Aladeniyi however stressed that there is an urgent need to educate the general public about the condition and create awareness that bedwetting is a medical condition that can be properly treated, disclosing that the global health authorities have realised the need to amplify public awareness about the condition by introducing World Bedwetting Day which was first marked in 2015 and was also celebrated on 28 May 2019.

READ
Resolving the PSN-Mora imbroglio

The World Bedwetting Day, he said, is a great avenue to create awareness that bedwetting is a disease that can and should be treated, noting that the more people become aware that something can be done, the more there will be reduction in crude methods of dealing with the condition by parents and the attendants negative effects of such negative treatments on children.

LEAVE A REPLY